The a2 Milk Company has reached an in principle agreement to settle a shareholder class action for $62 million, drawing a line under litigation tied to its FY21 earnings guidance.
In a market update, the company said the proceedings – filed in the Supreme Court of Victoria in late 2021 and later consolidated – related to disclosures made between 19 August 2020 and 9 May 2021, a period marked by significant disruption to its infant nutrition business.
The settlement sum, which includes interest and costs, will be fully covered by insurance and will not impact FY26 earnings. The company made no admission of liability, and the agreement remains subject to court approval.
The case centres on a turbulent period for a2MC, when pandemic-driven channel disruption – particularly the collapse of the daigou reseller network into China – triggered a sharp downgrade in FY21 guidance and a subsequent share price fall.
That period was a turning point for the company, prompting a reset of its China strategy, supply chain, and channel mix.
Since then, a2MC has sought to stabilise performance through a greater focus on direct distribution in China, expansion into new markets, and portfolio diversification beyond its core infant formula segment.
The settlement removes a key overhang for investors as the company continues its recovery phase. In recent reporting, a2MC has emphasised rebuilding revenue momentum and strengthening brand positioning in its key China and Australia-New Zealand markets, alongside disciplined cost management.
While the financial impact of the settlement is neutral at an earnings level, the resolution of the case is likely to be viewed as strategically significant, allowing management to focus fully on execution and growth initiatives without the distraction of ongoing litigation.
